Reliance Global Acquires Initial Stake in Quantum Cryptography Firm Enquantum

BenzingaBenzinga
|||1 min read
Key Takeaway

Reliance Global acquires 8% stake in quantum cryptography firm Enquantum, with potential path to majority ownership through $2.125 million milestone-based deal.

Reliance Global Acquires Initial Stake in Quantum Cryptography Firm Enquantum

Reliance Global Group (NASDAQ: EZRA) has completed its acquisition of an initial 8% stake in Enquantum Ltd., a developer of post-quantum cryptography solutions. The transaction represents the first phase of a structured deal that establishes a pathway toward majority ownership, with the company targeting 51% control through milestone-based achievements valued at $2.125 million. Enquantum's valuation was established at $9.8018 per share under the agreement terms.

Enquantum specializes in quantum-resilient encryption technology designed for high-throughput applications across critical infrastructure sectors. The company's cryptographic solutions address emerging security concerns within financial institutions, telecommunications networks, and government entities as quantum computing capabilities advance. This acquisition positions Reliance Global to expand its technology portfolio in cybersecurity and quantum-resistant data protection.

The milestone-based structure of the deal allows Reliance Global to increase its ownership stake contingent upon agreed-upon performance and development targets. This approach aligns the interests of both parties and establishes clear benchmarks for the progression of the strategic partnership between the two firms.

Source: Benzinga

Back to newsPublished Feb 23

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR